Mirae Asset Global Investments Co., Ltd. Mannkind Corp Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Mannkind Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,130 shares of MNKD stock, worth $54,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,130

Previous 186,532 95.64%

Holding current value

$54,145

Previous $844,000 95.02%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$4.05 - $5.43 $722,528 - $968,722	-178,402 Reduced 95.64%	8,130 $42,000
Q1 2024 May 01, 2024	BUY	$3.25 - $5.27 $32,493 - $52,689	9,998 Added 5.66%	186,532 $844,000
Q4 2023 Jan 24, 2024	BUY	$3.34 - $4.29 $4,472 - $5,744	1,339 Added 0.76%	176,534 $642,000
Q3 2023 Oct 26, 2023	SELL	$3.91 - $5.45 $26,623 - $37,109	-6,809 Reduced 3.74%	175,195 $723,000
Q2 2023 Aug 10, 2023	SELL	$3.72 - $4.79 $123,801 - $159,411	-33,280 Reduced 15.46%	182,004 $740,000
Q1 2023 May 04, 2023	BUY	$3.95 - $5.63 $274,777 - $391,645	69,564 Added 47.74%	215,284 $882,000
Q4 2022 Feb 09, 2023	BUY	$3.02 - $5.37 $4,016 - $7,142	1,330 Added 0.92%	145,720 $767,000
Q3 2022 Nov 10, 2022	BUY	$2.99 - $4.35 $68,871 - $100,197	23,034 Added 18.98%	144,390 $446,000
Q2 2022 Jul 26, 2022	BUY	$2.67 - $4.77 $205,680 - $367,452	77,034 Added 173.81%	121,356 $463,000
Q1 2022 May 10, 2022	SELL	$2.62 - $4.45 $9,185 - $15,601	-3,506 Reduced 7.33%	44,322 $163,000
Q4 2021 Feb 08, 2022	BUY	$4.05 - $5.37 $4,244 - $5,627	1,048 Added 2.24%	47,828 $209,000
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $18,341 - $25,838	4,715 Added 11.21%	46,780 $203,000
Q2 2021 Aug 11, 2021	BUY	$3.61 - $5.45 $151,854 - $229,254	42,065 New	42,065 $229,000

Others Institutions Holding MNKD

# of Institutions

219

Shares Held

133M

Call Options Held

1.43M

Put Options Held

851K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.71B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Mannkind Corp Transaction History